A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (IT-01)
- This topic has 0 replies, 1 voice, and was last updated 6 years, 1 month ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Thanks to Mary for bringing this to our attention.
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (IT-01)
https://clinicaltrials.gov/ct2/show/NCT03058289
The link above does not show CC as a qualifying cancer for the trial but it does show liver cancer amongst others as one of the qualifying cancers for enrolment in this trial. But Mary says that there is one CC patient on this trial hence why I am posting the link here on the boards.
As always with things, please consult your medical team for advice if this is something that could be of interest to you. Thanks to Mary for bringing this to my attention.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.